Antony A Riley's Net Worth
$937 Thousand
Who is Antony A Riley?
Antony A Riley does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Forte Biosciences, Inc., Krystal Biotech, Inc., and AVANEX CORP.
SEC CIK
Antony A Riley's CIK is 0001339375
Past Insider Trading and Trends
2006 was Antony A Riley's most active year for acquiring shares with 7 total transactions. Antony A Riley's most active month to acquire stocks was the month of February. 2006 was Antony A Riley's most active year for disposing of shares, totalling 6 transactions. Antony A Riley's most active month to dispose stocks was the month of February. 2023 saw Antony A Riley paying a total of $149,999.14 for 326,639 shares, this is the most they've acquired in one year. In 2021 Antony A Riley cashed out on 25,000 shares for a total of $106,105.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Forte Biosciences, Inc. (FBRX) Snapshot price: $0.5551
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.20% | 6.03K |
$0.71 | -$2,366.59 | 194.47K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| +3.03% | 5.53K |
$0.82 | -$3,156.15 | 188.44K |
Jan 1
| |||
Form 4
| +3.47% | 6.13K |
$0.66 | -$2,145.54 | 182.91K |
Oct 1
| |||
Form 4
| +525.49% | 148.51K |
$1.01 | $149,999.14 | 176.78K |
Jul 31
| |||
Form 4
| +32.93% | 6.13K |
$1.04 | -$3,370.64 | 24.76K |
Jul 1
| |||
Form 4
| +49.10% | 6.13K |
$1.01 | -$3,273.41 | 18.63K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| -69.32% | -25.00K |
$4.24 | -$106,105.48 | 11.06K |
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
| +22.82% | 6.7K |
$14.39 | $96,445.20 | 36.06K |
Jun 26 - Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Krystal Biotech, Inc. (KRYS) Snapshot price: $114.77
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +223.21% | 6.25K |
$9.85 | $61,562.50 | 9.05K |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
|
∞
| 2.8K |
$10.75 | $30,100.00 | 2.8K |
Mar 8 - May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANEX CORP No price found
V.P., Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +40.24% | 28.26K |
—
| $28.26 | 98.5K |
Mar 31
| |||
Form 4
| +18.00% | 10.71K |
—
|
—
| 70.23K |
Mar 21
| |||
Form 4
| +90.40% | 28.26K |
—
| $28.26 | 59.52K |
Dec 31
| |||
Form 4
| +942.35% | 28.26K |
$1.65 | $46,630.65 | 31.26K |
Scheduled
|
Oct 2
| ||
Form 4
| +110.62% | 31.26K |
$0.10 | $3,241.26 | 59.52K |
Aug 15 - Sep 30
| |||
Form 4
|
∞
| 28.26K |
—
| $28.26 | 28.26K |
Jun 30
| |||
Form 4
| -100.00% | -16.21K |
$1.99 | -$32,253.92 |
0
|
May 11
| |||
Form 4
|
∞
| 16.21K |
$3.15 | -$37,938.69 | 16.21K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||